Cleared Traditional

K211375 - Blazer™ Dx-20 Bidirectional Steerable Diagnostic Catheter (FDA 510(k) Clearance)

Sep 2021
Decision
129d
Days
Class 2
Risk

K211375 is an FDA 510(k) clearance for the Blazer™ Dx-20 Bidirectional Steerable Diagnostic Catheter. This device is classified as a Catheter, Electrode Recording, Or Probe, Electrode Recording (Class II - Special Controls, product code DRF).

Submitted by Boston Scientific Corporation (St Paul, US). The FDA issued a Cleared decision on September 10, 2021, 129 days after receiving the submission on May 4, 2021.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1220.

Submission Details

510(k) Number K211375 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 04, 2021
Decision Date September 10, 2021
Days to Decision 129 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code DRF — Catheter, Electrode Recording, Or Probe, Electrode Recording
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1220

Similar Devices — DRF Catheter, Electrode Recording, Or Probe, Electrode Recording

All 12
MAGiC Sweep™ EP Mapping Catheter
K250590 · Stereotaxis, Inc. · Jul 2025
VIKING™ Fixed Curve Diagnostic Catheter
K250310 · Boston Scientific Corporation · Jun 2025
EP•XT™ Unidirectional Steerable Diagnostic Catheter
K240366 · Boston Scientific Corporation · Nov 2024
Cosine-10TM Diagnostic Catheter
K233397 · Medtronic, Inc. · Dec 2023
Polaris X™ Unidirectional Steerable Diagnostic Catheter
K233207 · Boston Scientific Corporation · Oct 2023
BLAZER™ Dx-20 Bidirectional Steerable Diagnostic Catheter
K232651 · Boston Scientific Corporation · Sep 2023